MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmj.a1754

Медицинская библиотека · BMJ (Clinical research ed.) · 2008

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.

Dillner Joakim, Rebolj Matejka, Birembaut Philippe, Petry Karl-Ulrich, Szarewski Anne, Munk Christian, de Sanjose Silvia, Naucler Pontus, Lloveras Belen, Kjaer Susanne, Cuzick Jack, van Ballegooijen Marjolein, Clavel Christine, Iftner Thomas, Joint European Cohort Study

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To obtain large scale and generalisable data on the long term predictive value of cytology and human papillomavirus (HPV) testing for development of cervical intraepithelial neoplasia grade 3 or cancer (CIN3+).

DESIGN

Multinational cohort study with joint database analysis.

SETTING

Seven primary HPV screening studies in six European countries.

PARTICIPANTS

24,295 women attending cervical screening enrolled into HPV screening trials who had at least one cervical cytology or histopathology examination during follow-up.

MAIN OUTCOME MEASURE: Long term cumulative incidence of CIN3+.

RESULTS

The cumulative incidence rate of CIN3+ after six years was considerably lower among women negative for HPV at baseline (0.27%, 95% confidence interval 0.12% to 0.45%) than among women with negative results on cytology (0.97%, 0.53% to 1.34%)). By comparison, the cumulative incidence rate for women with negative cytology results at the most commonly recommended screening interval in Europe (three years) was 0.51% (0.23% to 0.77%). The cumulative incidence rate among women with negative cytology results who were positive for HPV increased continuously over time, reaching 10% at six years, whereas the rate among women with positive cytology results who were negative for HPV remained below 3%.

CONCLUSIONS

A consistently low six year cumulative incidence rate of CIN3+ among women negative for HPV suggests that cervical screening strategies in which women are screened for HPV every six years are safe and effective.

Для цитирования: Dillner Joakim, Rebolj Matejka, Birembaut Philippe, Petry Karl-Ulrich, Szarewski Anne, Munk Christian, de Sanjose Silvia, Naucler Pontus, Lloveras Belen, Kjaer Susanne, Cuzick Jack, van Ballegooijen Marjolein, Clavel Christine, Iftner Thomas, Joint European Cohort Study. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study.. BMJ (Clinical research ed.). 2008. DOI: 10.1136/bmj.a1754.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.